Objectives: To utilize bioluminescence to follow the effect of ciprofloxacin challenge on Pseudomonas aeruginosa biofilms.
Introduction
The ability of microorganisms to grow in biofilm mode has been researched extensively, yet there is still much to be learned about the tenacity of microorganisms adopting this lifestyle. The resistance properties of biofilm communities are thought to be a function of multiple factors including the physical structure of the biofilm, cellular growth status, general stress response and resistant subpopulations of cells. [1] [2] [3] It still remains unclear, however, the extent to which each of these factors contributes to biofilm intractability.
A range of in vitro laboratory models of biofilm growth is used by the biofilm research community, with various models (e.g. flow cells, continuous perfusion systems, microtitre plates), and the conditions under which they are used, often providing different snapshots of life in a biofilm. [4] [5] [6] [7] An inherent difficulty in the study of biofilms is that it is often necessary to physically disrupt them in order to investigate features of their constituent cell populations. This creates the potential disadvantage of biofilm-specific characteristics being lost. In attempts to avoid this, biofilm growth, activity and survival have been directly visualized with fluorescent probes and reporter genes. 8 Recently, there have been several studies utilizing bacterial bioluminescence as a tool to study surface-associated growth, both in vitro and in vivo. [9] [10] [11] [12] [13] An attractive feature of this approach is that cellular metabolic activity can be monitored in real-time, in a non-invasive manner, without the addition of an exogenous substrate. Light emission is catalysed by the enzyme luciferase, whereby molecular oxygen oxidizes both reduced flavin mononucleotide (FMNH 2 ) and a long-chain aldehyde to produce oxidized flavin (FMN), the corresponding long-chain fatty acid as well as blue-green light.
11 FMNH 2 depends upon functional electron transport, thus only metabolically active cells produce light. 14 We report here a study of a bioluminescent strain of Pseudomonas aeruginosa in an in vitro biofilm model, challenged with ciprofloxacin, a commonly used anti-pseudomonal fluoroquinolone. The effect on the biofilm was also monitored by conventional plate counts and by environmental scanning electron microscopy (ESEM).
Materials and methods
Bacterial strain and culture media P. aeruginosa PAO1 SEI was transformed with a recombinant plasmid containing the luxCDABE gene cassette of Photorhabdus luminescens. The recombinant plasmid, pMCS-5 lite, was constructed by insertion of the 7 kb EcoRI fragment from plasmid pLite27 15 into the broadhost-range plasmid pBBR1MCS-5 16 with the luxCDABE genes under the control of the constitutive p lac promoter. P. aeruginosa PAO1 SEI MCS5-lite was maintained on nutrient agar (NA) containing gentamicin (10 mg/L), the selective agent for the recombinant plasmid.
Iron-deplete chemically defined medium (CDM) consisted of glucose (40 mM), KCl (0.74 mM), NaCl (0.60 mM), (NH 4 ) 2 
Biofilm culture
Biofilms were grown using the Sorbarod in vitro biofilm culture system described previously. 17, 18 Briefly, 10 Sorbarods, pre-wetted with 5 mL of 0.85% saline, were inoculated with 1 mL of an exponential phase culture of P. aeruginosa PAO1 SEI MCS5-lite (1 · 10 8 cfu). CDM with gentamicin (10 mg/L), to maintain the plasmid, was delivered into the system at a controlled flow rate of 15 mL/h. Samples of eluate (eluted medium together with dispersed cells) were collected over time and quantified via viable counts [spiral plating onto NA + gentamicin (10 mg/L); spiral plater Autoplate model 3000, Spiral Biotech, Bethesda, MD, USA]. To assess the bioburden (number of viable cells within each Sorbarod), individual Sorbarod biofilms were broken down at various times and processed by vortexing as described previously. 17 All measurements were made in triplicate and statistical analyses were performed using GraphPad Prism version 3.00 for Windows (GraphPad Software, San Diego, CA, USA).
Bioluminescence was measured either in mV/mL using a 1250-001 luminometer (BioOrbit, Finland) at 37 C, or in photons/s using an ICCD photon counting camera (model 225, Photek, UK). Using the latter technique, photons emitted by P. aeruginosa PAO1 SEI MCS5-lite were quantified and analysed using IFS32 imaging software (Photek, UK). A 1% detector filter was employed for high population densities, to prevent camera damage. Biofilm and eluate samples were processed differently. Sorbarods, still intact in their PVC housings, were disconnected temporarily from the flow system for observation, while eluate samples (1 mL) were collected in microfuge tubes. Both samples were imaged by the ICCD camera mounted on a 37 C incubator. Photon emission data from samples were collected every second over a 30 s integration period, with the detector filter set at 1% and 100% for biofilm and eluate samples, respectively. All measurements were performed in triplicate and analysed statistically, as described previously.
Antibiotic perfusion of biofilms
The MIC of ciprofloxacin for P. aeruginosa PAO1 SEI MCS5-lite was determined by the broth macrodilution method. 19 In addition to use of standard Iso-Sensitest broth, the MIC was also determined in CDM. MIC determinations carried out in CDM were incubated for 24 h at 37 C, instead of the standard 18 h, due to the slower growth rate of P. aeruginosa in this minimal medium.
Sorbarod biofilms perfused with CDM and gentamicin (10 mg/L) for 24 h were deemed to be in quasi-steady-state (a constant number of cells/mL shed from the biofilm). Biofilms were then perfused with CDM (minus gentamicin) containing ciprofloxacin at 5 · MIC (5 mg/L, as determined both in Iso-Sensitest broth and in CDM), at a rate of 15 mL/h for 3 h, after which the medium was replaced with fresh CDM and gentamicin (10 mg/L). It should be noted that prior batch culture of P. aeruginosa in CDM without gentamicin had demonstrated that bioluminescence was not diminished over a 24 h period and also that chequerboard assay showed no interaction between gentamicin and ciprofloxacin (data not shown). Eluate cell numbers (cfu/mL) were allowed to recover to original levels before biofilms were challenged with ciprofloxacin (5 mg/L) for a second 3 h period. Bioluminescence levels and viable counts of eluate samples were monitored regularly throughout, while biofilm bioburdens were assessed less often due to the requirement for biofilm sacrifice to obtain population viable cell plate counts. NA plates contained 1% MgCl 2 .6H 2 O to inactivate any remaining ciprofloxacin in samples for viable counts. 20 Biofilms were run for a total of 100 h and the experiment carried out on three separate occasions.
Susceptibility testing of eluate and resuspended biofilm cells
To ascertain whether there were any changes in ciprofloxacin susceptibility of eluate and resuspended biofilm cells over the course of the study, MICs were assessed using antimicrobial strips (Etest Ò , AB BIODISK, Sweden). Resuspended biofilm samples were adjusted to give a 0.5 McFarland turbidity inoculum density, inoculated onto Iso-Sensitest plates and incubated at 35 C for 16-18 h. Eluate samples were pooled, allowed to grow to reach 0.5 McFarland turbidity, inoculated onto Iso-Sensitest plates and incubated as above.
Environmental scanning electron microscopy (ESEM)
Intact Sorbarod biofilms, pre-and post-ciprofloxacin perfusion (24, 75 , and 120 h), were fixed with 4% glutaraldehyde in 0.1 M phosphate buffer at pH 7.0 for 1 h. A non-inoculated Sorbarod, perfused with CDM for 24 h, was also prepared for analysis. Each Sorbarod was washed three times for 1 h with 0.1 M phosphate buffer at pH 7.0, then washed in sterile distilled water for 15 min and cut vertically to 2.5 mm thickness. Samples were examined using a Philips XL 30 ESEM together with a gaseous secondary electron detector. Samples were cooled to 5 C and initially viewed at 7.5 Torr. The pressure was reduced to evaporate water and expose the biofilm and fibres in conditions of high relative humidity.
Results
Previous work with P. aeruginosa PAO1 SEI MCS5-lite has demonstrated that bioluminescence of this organism (mV/mL) is directly correlated to viable counts (cfu/mL) in batch cultures in the same growth phase. 11 In this present study, it was confirmed that bioluminescence levels could be used as a reliable indicator of cell numbers in the Sorbarod biofilm system, with eluate bioluminescence levels (mV/mL) indicating quasi-steady-state of control biofilms in similar fashion to the more traditionally used viable cell counts (Figure 1a) . Bioluminescence monitored by ICCD camera (photons/s/mL) showed a similar pattern to bioluminescence monitored by luminometer (mV/mL) ( Figure 1a) .
Perfusion of biofilms with ciprofloxacin
The results of perfusion of 24 h quasi-steady-state biofilms with ciprofloxacin for 3 h, followed by a period of recovery before a second 3 h challenge, are presented in Figure 1(b) . Bioluminescence levels (mV/mL and photon counts/s/mL) and viable counts (cfu/mL) were followed throughout. After the first 3 h of ciprofloxacin perfusion, eluate bioluminescence levels had decreased 1.61 log (mV/mL) and 1.52 log (photons/s/mL) in comparison with their respective controls, whereas viable counts had declined 3.88 log in comparison with controls. Eluate viable counts appeared to indicate that recovery began 3 h after cessation of drug perfusion, whereas bioluminescence (mV/mL) only began to increase 20 h later. Eluate photon counts indicated a similar prolonged recovery time. Following the second ciprofloxacin perfusion, it was again noted that eluate viable counts were increasing while both types of bioluminescence measurements were still indicating a decline in cellular metabolic activity.
Resuspended biofilm viable cell counts and intact biofilm bioluminescence ICCD data (photons/s/mL) for control Sorbarod biofilms (Figure 2) showed increases in the biofilm bioburdens of 0.5 log over the 130 h time period studied (i.e. biofilms were in quasi-steady-state). Challenge of the biofilms with ciprofloxacin resulted in a drop in biofilm bioburden of at least 2 log cfu/mL, while bioluminescence (photons/s) of the intact biofilms declined less than 1 log, for those time points monitored. As with eluate samples, viable counts indicated recovery of the biofilm population, while bioluminescence levels were still in decline. However, bioluminescence dropped little following the second challenge with ciprofloxacin, for those time points monitored, in contrast to the 2 log decrease observed for viable counts.
Imaging of intact biofilms
Photon emission analyses of intact biofilms were carried out over an integration time of 30 s. During that time, an image was recorded that allowed spatial distribution of levels of bioluminescence within the Sorbarod filter to be visualized (Figure 3 ). Images were analysed at different time points: quasi-steady-states (time points 24, 72.5 and 125 h), immediately after ciprofloxacin challenges (time points 27 and 75.5 h) and 20 h after cessation of both challenges (47 and 95.5 h). At 24 h, photon emission was most intense at the top of the Sorbarod (Figure 3a) . A similar distribution, although higher photon output, was observed in the second quasi-steadystate (72.5 h) (Figure 3d ). Twenty hours following the first ciprofloxacin perfusion (Figure 3c ), photon emission was clearly most intense in the upper third of the Sorbarod, with relatively sparse output in the lowest third. Twenty hours after the second drug challenge (Figure 3f ), photon output was again greatest in the upper third of the Sorbarod, but in comparison to Figure 3(c) , photon intensity was far greater throughout. Immediately following ciprofloxacin perfusions (Figure 3b and e), photon emission was higher (compared with previous quasi-steady-states) and distributed uniformly throughout the Sorbarod. Photon emission from a final quasi-steady-state biofilm (Figure 3g) and from a control, non-challenged biofilm of the same age (Figure 3h ) was identical in terms of overall numbers of photons. However, while emission from the control, was homogeneously distributed throughout the Sorbarod, this was not the case for the drug-challenged Sorbarod, where emission was more intense at the top of the filter.
ESEM analysis of biofilms
A representative example of quasi-steady-state (24 h old) biofilm is shown in Figure 4(a) . Clumps of cells and individual cells were visible at the surfaces of well-defined three-dimensional biofilm structures-these structures presumably consisting of pseudomonal extracellular polymeric substances (EPS). No such welldefined structures were observed in biofilms sampled following ciprofloxacin challenge, a representative example of which is shown in Figure 4(b) . Bacterial cells, elongated to a size of 4 or 5 mm, were visible within the mass of EPS. As biofilms recovered post-challenge and reached quasi-steady-state once again, they appeared less disaggregated and there were more threedimensional structures composed of EPS and mixed populations of short and long rods (Figure 4c) . The non-drug-challenged biofilm sample of the same age contained smooth, protruding, well-defined biofilm masses, an example of which is shown (Figure 4d ). Bacterial cells of 2 mm in length were visible on the surface of these structures.
Susceptibility of eluate and resuspended biofilm cells
Samples of eluate and biofilm cells were taken at various time points over the course of biofilm perfusion experiments, and ciprofloxacin MICs ascertained using Etest Ò strips (Table 1) . Biofilm samples only showed a significant decrease in susceptibility to ciprofloxacin (MIC 6-fold greater than pre-exposure levels) following the second challenge with ciprofloxacin, when biofilms were being allowed to recover at 95.5 h. Eluate cell MICs increased immediately following the first drug perfusion, declined, then increased significantly (to eight times the original MIC value) immediately following the second perfusion. MIC values declined thereafter, although remained greater than those of control, nonchallenged, eluate cells.
Discussion
Measurement of bioluminescence from P. aeruginosa SEI MCS5-lite cells, eluted from biofilms by single tube luminometer (mV/mL) and by ICCD camera (photons/s/mL) gave consistently similar results. Use of the ICCD camera, however, gave the distinct advantage of enabling imaging of intact Sorbarod-grown biofilms. Both viable and photon count methods indicated that, over the time period studied, the Sorbarod biofilm bioburden increased gradually. This illustrates the reason for the term 'quasi-steadystate' when describing Sorbarod biofilm data, i.e. while the number of cells/mL shed in the biofilm eluate varies little over time, if all conditions remain unaltered, the actual biofilm population is slowly increasing, indicating that a proportion of newly divided cells are retained within the Sorbarod filter.
Monitoring the effect of 3 h exposures of ciprofloxacin on biofilms, using bioluminescence measurements, yielded some interesting differences when compared with viable count data for the same samples. The log decline in eluate viable cell counts was always greater than the decline in bioluminescence over the same time periods. Furthermore, when eluate viable counts began to increase, indicating recovery of the biofilm populations, bioluminescence measurements were still in decline. These findings are consistent with those reported previously, for fluoroquinolonechallenged planktonic and biofilm cultures. 11, 21 There are several possible explanations for these apparent differences. The direct target of ciprofloxacin in the bacterial cell is not that of energygenerating metabolic processes; therefore, the real-time measurements of bioluminescence would not be affected to a great extent on initial challenge with this agent. After cessation of drug-exposure, however, the cells could be directing their metabolism towards recovery and repair processes, rather than light emission. Moreover, unlike bioluminescence, viable counts do not give real-time measurements. Drug-challenged cells plated onto agar may either be irretrievably injured and unable to develop into observable colonies, or they may recover and ultimately be enumerated as cfu. The more rapid 'recovery' of the biofilm indicated by eluate colony counts suggests that injured cells may indeed have been able to recover on agar. An alternative explanation might be that biofilm cells were elongated as a consequence of ciprofloxacin exposure.
22
On removal of the drug, filaments divided into individual cells, with a resultant increase in cfu in the eluate but no increase in bioluminescence.
The effect of ciprofloxacin on biofilm bioburden was not as great as that seen on eluted cell viable counts, for the same sample points. It was notable, though, that bioburden viable counts again declined significantly more than photon counts. Indeed, for those samples taken, the decline in photons as a result of the second drug challenge was relatively minor. The ciprofloxacin MICs for eluate and resuspended biofilm cells increased after both drug challenges and, although they subsequently declined, they did not return to pre-exposure levels within the time period studied. It is possible that the drug challenges selected for a resistant sub-population of cells that were less able to predominate under normal conditions. The presence of resistant sub-populations of cells within biofilms has been indicated previously, 23 although in this present work, use of a range of ciprofloxacin concentrations would be required to identify the presence of markedly resistant cells.
It is also possible that ciprofloxacin was being removed from the cells via efflux, although the fluoroquinolones are not known inducers of efflux mechanisms in P. aeruginosa. Ciprofloxacin is, however, a substrate for the constitutively expressed MexABOprM efflux system, 24 but this would not account for the transient increase in MICs. Furthermore, there is no evidence, to date, that efflux pump expression in biofilms is up-regulated. 25, 18 Using the colony biofilm technique, 26 it has been shown that oxygen limitation plays an important protective role in antimicrobial-challenged P. aeruginosa biofilms. 27, 28 In this current study, oxygen levels within the biofilm were not monitored. Since bioluminescence is an oxygen-dependent phenomenon, and there is no decline in photon counts for 125 h control biofilms, it could be surmised that mature biofilms grown by this continuous perfusion method were not severely oxygen-limited. It has been reported that bioluminescence is detectable at oxygen concentrations as low as 10 nM 29 and it is tempting to speculate that direct imaging of intact biofilms by ICCD camera may be able to distinguish aerobic from strictly anaerobic areas within a bioluminescent P. aeruginosa biofilm that is otherwise nutritionally complete.
There are relatively few published studies that use ESEM as a means to visualize biofilm structure. This current work has demonstrated that it allows informative visualization of the threedimensional structure of biofilms. Ciprofloxacin challenge clearly resulted in loss of biofilm integrity, with ESEM images showing what appeared to be a morass of cells and EPS post-drug exposure, as opposed to the more defined structures seen pre-exposure and in control samples. Nevertheless, the biofilm architecture appeared to be rebuilt as the biofilms recovered to quasi-steady-state. Further evidence of biofilm recovery was provided by direct visualization of intact biofilms by ICCD camera and the photon data acquired. This demonstrated that, following the second ciprofloxacin perfusion, the extent of photon emission differed little from intact biofilms in quasi-steady-state, although the distribution of highly bioluminescent cells altered with time. This phenomenon warrants further investigation, with more frequent observation of the intact biofilms using the ICCD.
Bioluminescence and viable counts measure different aspects of cell physiology and neither should be regarded as the definitive indicator of cell viability. Bioluminescence, however, can provide important data regarding cellular activity within the biofilm. The bioluminescence readings from resuspended biofilms and the photon camera images of intact biofilms both measure the metabolically active biomass within a biofilm in real time and suggest that challenge with ciprofloxacin has less effect on metabolism than on viable counts. This is particularly apparent after the second ciprofloxacin challenge and the data could have clinical significance in the elucidation of the persistence of biofilms after antibiotic treatment.
